See the DrugPatentWatch profile for pravastatin

Pravastatin and Lipitor are both medications used to lower cholesterol levels, but they have different prices due to several factors, including patent protection and branding.

Pravastatin is a generic drug that has been available for many years, and its patent has expired [1]. As a result, there are multiple manufacturers producing this medication, leading to increased competition and lower prices. Pravastatin is available as a generic drug in various strengths, and its cost is relatively affordable.

Lipitor, on the other hand, is a brand-name drug that contains atorvastatin [2]. Lipitor was introduced to the market before pravastatin's patent expiration, and it enjoyed several years of market exclusivity. During this time, Lipitor was the only option for patients seeking this type of cholesterol-lowering medication. Since Lipitor is still under patent protection in some countries, it is more expensive than pravastatin [3].

In summary, the price difference between pravastatin and Lipitor is primarily due to patent protection and competition. Pravastatin, being a generic drug, has multiple manufacturers and increased competition, leading to lower prices. In contrast, Lipitor is a brand-name drug still under patent protection in some regions, resulting in higher prices.

Sources:

1. DrugPatentWatch.com. (n.d.). Pravastatin. Retrieved from <https://www.drugpatentwatch.com/drugs/pravastatin>
2. Mayo Clinic. (2022, February 11). Atorvastatin (Oral Route) - Mayo Clinic. Retrieved from <https://www.mayoclinic.org/drugs-supplements/atorvastatin-oral-route/description/drg-20063051>
3. Drugs.com. (2022, March 21). Pravastatin vs Lipitor. Retrieved from <https://www.drugs.com/compare/pravastatin-vs-lipitor.html>